Medicine & Life Sciences
Pharmacokinetics
100%
gemcitabine
99%
Neoplasms
99%
Pancreatic Neoplasms
97%
Oxaliplatin
81%
Colorectal Neoplasms
71%
Irinotecan
60%
Adenocarcinoma
55%
130-nm albumin-bound paclitaxel
49%
Survival
46%
Fluorouracil
44%
Maximum Tolerated Dose
38%
Therapeutics
33%
belotecan
33%
Leucovorin
32%
Appointments and Schedules
31%
Safety
30%
rubitecan
27%
Paclitaxel
27%
National Cancer Institute (U.S.)
26%
Docetaxel
25%
Drug Therapy
23%
tanespimycin
23%
Progression-Free Survival
22%
Capecitabine
18%
2-amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo(1,2-c)quinazolin-4-yl)pyrimidine-5-carboxamide
18%
Biliary Tract Neoplasms
17%
Neutropenia
17%
Imatinib Mesylate
17%
Non-Small Cell Lung Carcinoma
17%
Bevacizumab
16%
Erlotinib Hydrochloride
16%
Diarrhea
16%
Pemetrexed
16%
veliparib
15%
Fatigue
15%
Thioredoxins
15%
Pancreas
15%
9-aminocamptothecin
15%
Carboplatin
14%
Clinical Trials
14%
Albumin-Bound Paclitaxel
13%
Cisplatin
13%
HSP90 Heat-Shock Proteins
13%
CGP 74588
13%
Cetuximab
13%
Nausea
12%
N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
12%
Liver
12%